Annual ROE
-90.39%
-49.72%-122.25%
December 31, 2023
Summary
- As of February 8, 2025, ATHA annual return on equity is -90.39%, with the most recent change of -49.72% (-122.25%) on December 31, 2023.
- During the last 3 years, ATHA annual ROE has fallen by -83.11% (-1141.62%).
- ATHA annual ROE is now -363.99% below its all-time high of 34.24%, reached on December 31, 2018.
Performance
ATHA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-115.63%
-20.10%-21.04%
September 30, 2024
Summary
- As of February 8, 2025, ATHA quarterly return on equity is -115.63%, with the most recent change of -20.10% (-21.04%) on September 30, 2024.
- Over the past year, ATHA quarterly ROE has dropped by -46.52% (-67.31%).
- ATHA quarterly ROE is now -629.20% below its all-time high of 21.85%, reached on March 31, 2020.
Performance
ATHA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ATHA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -122.3% | -67.3% |
| 3 y3 years | -1141.6% | -67.3% |
| 5 y5 years | -364.0% | -67.3% |
ATHA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -429.2% | at low | -622.7% | at low |
| 5 y | 5-year | -445.4% | at low | -629.2% | at low |
| alltime | all time | -364.0% | at low | -629.2% | at low |
Athira Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -115.63%(+21.0%) |
| Jun 2024 | - | -95.53%(+18.5%) |
| Mar 2024 | - | -80.59%(+16.6%) |
| Dec 2023 | -90.39%(+122.3%) | -69.11%(+12.7%) |
| Sep 2023 | - | -61.33%(+27.2%) |
| Jun 2023 | - | -48.23%(+16.4%) |
| Mar 2023 | - | -41.44%(+17.0%) |
| Dec 2022 | -40.67% | -35.42%(+26.1%) |
| Sep 2022 | - | -28.08%(+12.5%) |
| Jun 2022 | - | -24.95%(+22.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -20.45%(+27.8%) |
| Dec 2021 | -17.08%(+134.6%) | -16.00%(+14.6%) |
| Sep 2021 | - | -13.96%(+11.7%) |
| Jun 2021 | - | -12.50%(+13.0%) |
| Mar 2021 | - | -11.06%(+13.3%) |
| Dec 2020 | -7.28%(-127.8%) | -9.76%(-21.4%) |
| Sep 2020 | - | -12.41%(-40.7%) |
| Jun 2020 | - | -20.93%(-195.8%) |
| Mar 2020 | - | 21.85%(+72.0%) |
| Dec 2019 | 26.17%(-23.6%) | 12.70% |
| Dec 2018 | 34.24% | - |
FAQ
- What is Athira Pharma annual return on equity?
- What is the all time high annual ROE for Athira Pharma?
- What is Athira Pharma annual ROE year-on-year change?
- What is Athira Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Athira Pharma?
- What is Athira Pharma quarterly ROE year-on-year change?
What is Athira Pharma annual return on equity?
The current annual ROE of ATHA is -90.39%
What is the all time high annual ROE for Athira Pharma?
Athira Pharma all-time high annual return on equity is 34.24%
What is Athira Pharma annual ROE year-on-year change?
Over the past year, ATHA annual return on equity has changed by -49.72% (-122.25%)
What is Athira Pharma quarterly return on equity?
The current quarterly ROE of ATHA is -115.63%
What is the all time high quarterly ROE for Athira Pharma?
Athira Pharma all-time high quarterly return on equity is 21.85%
What is Athira Pharma quarterly ROE year-on-year change?
Over the past year, ATHA quarterly return on equity has changed by -46.52% (-67.31%)